Modification and morphology of human umbilical cord vein as canine arterial bypass grafts
- PMID: 7369809
- PMCID: PMC1344565
- DOI: 10.1097/00000658-198004000-00009
Modification and morphology of human umbilical cord vein as canine arterial bypass grafts
Abstract
Human umbilical cord veins treated with various concentrations of glutaraldehyde (GA) and ethanol (ET) were used to replace short segments of the infrarenal abdominal artery in 40 dogs. The patency rates were 62.5% (5/8) in Group I; tanned with 1% GA for 24 hours and preserved in the same solution 87.5% (7/8) in Group II; tanned with 1% GA for 24 hours and preserved in 50% ethanol, 100% (8/8) in Group III; tanned in the same manner as Group II, but preserved in 70% ET; 87.5% (7/8) in Group IV; tanned with 0.5% GA for 24 hours and preserved in 50% ET, and 87.5% (7/8) in Group V; tanned as in Group IV but preserved in 70% ET when examined 14 days to 6 months after implantation. Angiographically, most of the anastomotic lines gradually contracted with the lapse of time because of excessive proliferation of connective tissue into the intraluminal surfaces, although the structural integrity of the graft was well preserved. Microscopically, the irregular fibrin membrane covering the entire inner surface of the graft became smoother and thinner with the lapse of time. The pannus increased gradually both in thickness and width. Scanning electron-micrography of the graft revealed that no endothelial cells were found more than 5 mm from the suture lines even 6 months after implantation. Antigenicity of the graft using a complement-dependent cytotoxicity test was effectively suppressed with glutaraldehyde regardless of whether its concentration was 0.5% or 1.0%. Although human umbilical cord vein tanned with 0.5% glutaraldehyde and preserved in 50% ethanol until used was considered to be useful as an arterial substitute, final conclusion could not be drawn since six grafts followed for six months, the longest follow-up, were stenotic.
Similar articles
-
Human umbilical cord vein as arterial substitute in the dog.Ann Chir Gynaecol. 1981;70(2):61-4. Ann Chir Gynaecol. 1981. PMID: 6459050
-
Glutaraldehyde pre-treated human saphenous and umbilical veins as xenogeneic small vessel substitutes and shunts in dogs.Ann Chir Gynaecol. 1981;70(1):11-7. Ann Chir Gynaecol. 1981. PMID: 7259055
-
Glutaraldehyde-tanned ovine collagen conduits as vascular xenografts in dogs: a preliminary report.Arch Surg. 1980 Aug;115(8):967-9. doi: 10.1001/archsurg.1980.01380080057011. Arch Surg. 1980. PMID: 6772139
-
Scanning electron microscopy evaluation of porous and nonporous arterial substitutes.Surg Gynecol Obstet. 1982 Sep;155(3):358-62. Surg Gynecol Obstet. 1982. PMID: 6214034
-
Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases.J Vasc Surg. 2002 Jan;35(1):64-71. J Vasc Surg. 2002. PMID: 11802134 Review.
Cited by
-
Preparation of venous allografts. A comparison of techniques.Ann Surg. 1984 Aug;200(2):117-30. doi: 10.1097/00000658-198408000-00002. Ann Surg. 1984. PMID: 6431915 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources